BetterLife Pharma Inc. (CSE:BETR)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
-0.0050 (-7.69%)
Oct 30, 2025, 10:33 AM EDT
-7.69%
Market Cap10.19M
Revenue (ttm)n/a
Net Income (ttm)-839.95K
Shares Outn/a
EPS (ttm)-0.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Average Volume141,050
Open0.0600
Previous Close0.0650
Day's Range0.0600 - 0.0600
52-Week Range0.0550 - 0.1750
Beta1.16
RSI43.87
Earnings DateDec 29, 2025

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to t... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 7
Stock Exchange Canadian Securities Exchange
Ticker Symbol BETR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.